In this study, we investigated the relationships between serum IGF-1 levels and psychiatric symptoms in patients with chronic schizophrenia and analyzed the association between serum IGF-1 levels and diabetes, antipsychotic drug use, and duration of illness. Here, IGF1 is linked to diabetes mellitus.